IP Library › Patent Application 18379470
Patent Application
App. No. 18/379,470

MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS, METHODS OF MANUFACTURING AND USE OF THE SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/379,470
Abstract

Oil compositions and compositions thereof that can form nanoemulsions or microemulsions are disclosed. Such compositions and compositions thereof can be useful for antimicrobial properties and be used to treat or prevent microbial infections.

Claims (22)

1 . A method of treating or preventing a microbial infection in a subject in need thereof, comprising:

administering to the subject an effective amount of an antimicrobial oil composition comprising at least 10% free fatty acids (FFAs) by weight out of the total weight of the antimicrobial oil composition, wherein the antimicrobial oil composition comprises less than 5% triacylglycerols (TAGs) by weight out of the total weight of the antimicrobial oil composition.

2 . The method of claim 1 , wherein the antimicrobial oil composition further comprises from about 5% to about 70% monoacylglycerols (MAGs) by weight out of the total weight of the antimicrobial oil composition.

3 . The method of claim 2 , wherein the MAGs are derived from a first oil source.

4 . The method of claim 2 , wherein the FFAs are derived from a first oil source and a second oil source.

5 . The method of claim 4 , wherein the first oil source and the second oil source a different oils. T

6 . The method of claim 1 , wherein the antimicrobial oil composition comprises from about 10% to about 100% FFAs by weight out of the total weight of the antimicrobial oil composition.

7 . The method of claim 1 , wherein the antimicrobial oil composition is administered in the form of a cream, a lotion, a body wash, or a lubricant, such as vaginal lubricant.

8 . The method of claim 1 , wherein the antimicrobial oil composition is a plant oil or a mix of two or more plant oils.

9 . The method of claim 1 , wherein the antimicrobial oil composition comprises a mixture of a first amount of an enzyme-modified oil (EMO) derived from a first oil source and a second amount of a FFA oil derived from a second oil source.

10 . The method of claim 1 , wherein the antimicrobial oil composition is part of a microemulsion.

11 . The method of claim 1 , wherein the antimicrobial oil composition is part of a nanoemulsion.

12 . The method of claim 11 , wherein the antimicrobial oil composition does not include any exogenous additive with surfactant and/or emulsifier properties that is not naturally present in the oil in an amount sufficient to enhance droplet stability.

13 . The composition of claim 11 , wherein the composition does not include any exogenous additive with thickening or crystallization inhibiting properties that is not naturally present in the oil in an amount sufficient to thicken the composition or inhibit crystallization formation, respectively

14 . The method of claim 1 , wherein the antimicrobial oil composition has a minimum inhibitory concentration (MIC) of 100 μg/mL or less against a bacteria selected from the group consisting of Bacillus cereus, Streptococcus mutans, Staphylococcus epidermidis, Enterococcus faecalis, Listeria monocytogenes, Streptococcus pyogenes, Streptococcus agalactiae, Cutibacterium acnes, Staphylococcus aureus, Helicobacter pylori , and Pseudomonas aeruginosa , or wherein the antimicrobial oil composition has a minimum bactericidal concentration (MBC) of 100 μg/mL or less against a bacteria selected from the group consisting of Bacillus cereus, Streptococcus mutans, Staphylococcus epidermidis, Enterococcus faecalis, Listeria monocytogenes, Streptococcus pyogenes, Streptococcus agalactiae, Cutibacterium acnes, Staphylococcus aureus, Helicobacter pylori , and Pseudomonas aeruginosa.

15 . The method of claim 1 , wherein the antimicrobial oil composition selectively inhibits or kills S. aureus more effectively than S. epidermidis, S. hominis , and S. capitis.

16 . The method of claim 1 , wherein the antimicrobial oil composition is administered topically.

17 . An article comprising a condom and a lubricant composition on a surface of the condom, wherein the lubricant composition comprises an oil composition, wherein the oil composition comprises at least 10% free fatty acids (FFAs) by weight out of the total weight of the oil composition, wherein the oil composition comprises less than 5% triacylglycerols (TAGs) by weight out of the total weight of the oil composition.

18 . The article of claim 17 , wherein the oil composition is a plant-based oil.

19 . A method for treating or preventing a skin condition in a subject in need thereof, comprising:

applying a cream composition to the skin of the subject, the cream composition further comprising an oil composition, wherein the oil composition comprises at least 10% free fatty acids (FFAs) by weight out of the total weight of the oil composition, wherein the oil composition comprises less than 5% triacylglycerols (TAGs) by weight out of the total weight of the oil composition.

20 . The method of claim 19 , wherein the skin condition is atopic dermatitis or eczema.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2025
From: MONTICELLO, DANIEL J.; SCHOCKER, NATHANIEL SCOTT; STEVENS, DAVID MICHAEL
To: GLYCOSBIO INC.
Reel/Frame 070330/0806 →